• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCL14在前列腺癌中的作用:肿瘤微环境中的复杂相互作用及未来展望

CXCL14 in prostate cancer: complex interactions in the tumor microenvironment and future prospects.

作者信息

Tang Lei, Chen Xin, Hou Jianquan, Wei Xuedong

机构信息

Department of Urology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, 215006, People's Republic of China.

Department of Urology, The First Affiliated Hospital of Soochow University, No. 899 Pinghai Road, Suzhou, 215006, People's Republic of China.

出版信息

J Transl Med. 2025 Jan 4;23(1):9. doi: 10.1186/s12967-024-06022-9.

DOI:10.1186/s12967-024-06022-9
PMID:39755616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11700453/
Abstract

CXCL14 is a highly conserved chemokine expressed in various cell types, playing crucial roles in both physiological and pathological processes, including immune regulation and tumorigenesis. Recently, the role of CXCL14 in tumors has attracted considerable attention. However, previous pan-cancer studies have reported inconsistencies regarding the effects of CXCL14 on tumors, particularly concerning its expression levels in tumor tissues and its influence on various phenotypes of cancer cells. This variability is believed to stem from the context-dependent nature of CXCL14, as different sources of CXCL14 and its secretion within distinct tumor microenvironments may mediate diverse biological effects. Such phenomena have also been observed in prostate cancer research. Despite a foundational understanding of CXCL14 in prostate cancer, there remains a lack of comprehensive reviews summarizing the specific roles of this chemokine and systematically analyzing the reasons behind its complex effects. Therefore, this article aims to discuss the role of CXCL14 in the tumor microenvironment of prostate cancer and explore future research directions and potential applications.

摘要

CXCL14是一种在多种细胞类型中表达的高度保守的趋化因子,在包括免疫调节和肿瘤发生在内的生理和病理过程中发挥着关键作用。最近,CXCL14在肿瘤中的作用引起了相当大的关注。然而,先前的泛癌研究报告了CXCL14对肿瘤影响的不一致性,特别是关于其在肿瘤组织中的表达水平及其对癌细胞各种表型的影响。这种变异性被认为源于CXCL14的背景依赖性,因为不同来源的CXCL14及其在不同肿瘤微环境中的分泌可能介导不同的生物学效应。这种现象在前列腺癌研究中也有观察到。尽管对前列腺癌中的CXCL14有了基本的了解,但仍然缺乏全面的综述来总结这种趋化因子的具体作用,并系统地分析其复杂效应背后的原因。因此,本文旨在探讨CXCL14在前列腺癌肿瘤微环境中的作用,并探索未来的研究方向和潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d17/11700453/9cdfd6f171bb/12967_2024_6022_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d17/11700453/1fd3415ffd2e/12967_2024_6022_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d17/11700453/0092104d9b43/12967_2024_6022_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d17/11700453/81812f2d4a52/12967_2024_6022_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d17/11700453/9cdfd6f171bb/12967_2024_6022_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d17/11700453/1fd3415ffd2e/12967_2024_6022_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d17/11700453/0092104d9b43/12967_2024_6022_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d17/11700453/81812f2d4a52/12967_2024_6022_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d17/11700453/9cdfd6f171bb/12967_2024_6022_Fig4_HTML.jpg

相似文献

1
CXCL14 in prostate cancer: complex interactions in the tumor microenvironment and future prospects.CXCL14在前列腺癌中的作用:肿瘤微环境中的复杂相互作用及未来展望
J Transl Med. 2025 Jan 4;23(1):9. doi: 10.1186/s12967-024-06022-9.
2
The roles of Y-box-binding protein (YB)-1 and C-X-C motif chemokine ligand 14 (CXCL14) in the progression of prostate cancer via extracellular-signal-regulated kinase (ERK) signaling.Y 盒结合蛋白 (YB)-1 和 C-X-C 基序趋化因子配体 14 (CXCL14) 通过细胞外信号调节激酶 (ERK) 信号通路在前列腺癌进展中的作用。
Bioengineered. 2021 Dec;12(2):9128-9139. doi: 10.1080/21655979.2021.1993537.
3
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.CXCL14是成纤维细胞的自分泌生长因子,也是前列腺肿瘤生长的多模式刺激因子。
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3414-9. doi: 10.1073/pnas.0813144106. Epub 2009 Feb 13.
4
Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells.促迁移趋化因子 CXCL14 在人前列腺癌细胞中的促迁移调节的表观遗传机制。
Cancer Res. 2010 Jun 1;70(11):4394-401. doi: 10.1158/0008-5472.CAN-10-0427. Epub 2010 May 11.
5
Chemokine CXCL14; a double-edged sword in cancer development.趋化因子 CXCL14:癌症发展中的双刃剑。
Int Immunopharmacol. 2021 Aug;97:107681. doi: 10.1016/j.intimp.2021.107681. Epub 2021 Apr 28.
6
Modulation of CXCL14 (BRAK) expression in prostate cancer.前列腺癌中CXCL14(BRAK)表达的调控
Prostate. 2005 Jun 15;64(1):67-74. doi: 10.1002/pros.20215.
7
CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent Manner.CXCL14 通过调节肿瘤微环境中的免疫特征以依赖 T 细胞的方式抑制三阴性乳腺癌的进展。
Int J Mol Sci. 2022 Aug 18;23(16):9314. doi: 10.3390/ijms23169314.
8
The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.趋化因子 CXCL14 的表达与胶质母细胞瘤的多个侵袭性方面相关,并促进胶质母细胞瘤细胞的关键特性。
Int J Mol Sci. 2019 May 21;20(10):2496. doi: 10.3390/ijms20102496.
9
The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses.趋化因子 CXCL14 在癌症进展和免疫反应中的多样角色。
Mol Carcinog. 2020 Jul;59(7):794-806. doi: 10.1002/mc.23188. Epub 2020 Mar 24.
10
Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals.CXCL14 是 CXC 型趋化因子家族的成员,对多种细胞具有趋化作用。
J Biochem. 2012 May;151(5):469-76. doi: 10.1093/jb/mvs030. Epub 2012 Mar 20.

引用本文的文献

1
Revisiting the role of cancer-associated fibroblasts in tumor microenvironment.重新审视癌症相关成纤维细胞在肿瘤微环境中的作用。
Front Immunol. 2025 Apr 17;16:1582532. doi: 10.3389/fimmu.2025.1582532. eCollection 2025.

本文引用的文献

1
Design, synthesis, and characterization of an Ag-Bi-S-based multifunctional nanotheranostic platform.基于Ag-Bi-S的多功能纳米诊疗平台的设计、合成与表征
J Mater Chem B. 2025 Jan 15;13(3):888-893. doi: 10.1039/d4tb02502d.
2
Impact of age on genomic alterations and the tumor immune microenvironment in papillary thyroid cancer.年龄对甲状腺乳头状癌基因组改变和肿瘤免疫微环境的影响。
Endocr Relat Cancer. 2024 Nov 4;31(12). doi: 10.1530/ERC-23-0341. Print 2024 Dec 1.
3
Immunologically effective biomaterials enhance immunotherapy of prostate cancer.
具有免疫效应的生物材料可增强前列腺癌的免疫治疗效果。
J Mater Chem B. 2024 Oct 9;12(39):9821-9834. doi: 10.1039/d3tb03044j.
4
Epitranscriptomic mechanisms of androgen signalling and prostate cancer.雄激素信号转导和前列腺癌的表观转录组学机制。
Neoplasia. 2024 Oct;56:101032. doi: 10.1016/j.neo.2024.101032. Epub 2024 Jul 20.
5
Long-read RNA sequencing can probe organelle genome pervasive transcription.长读长RNA测序能够探究细胞器基因组的广泛转录。
Brief Funct Genomics. 2024 Dec 6;23(6):695-701. doi: 10.1093/bfgp/elae026.
6
PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer.靶向雄激素受体信号的 PROTACs:用于治疗去势抵抗性前列腺癌的潜在治疗剂。
Pharmacol Res. 2024 Jul;205:107234. doi: 10.1016/j.phrs.2024.107234. Epub 2024 May 28.
7
Macrophage polarization: an important role in inflammatory diseases.巨噬细胞极化:在炎症性疾病中的重要作用。
Front Immunol. 2024 Apr 10;15:1352946. doi: 10.3389/fimmu.2024.1352946. eCollection 2024.
8
Integration Analysis of Single-Cell Multi-Omics Reveals Prostate Cancer Heterogeneity.单细胞多组学整合分析揭示前列腺癌异质性。
Adv Sci (Weinh). 2024 May;11(18):e2305724. doi: 10.1002/advs.202305724. Epub 2024 Mar 14.
9
Dendritic cells as orchestrators of anticancer immunity and immunotherapy.树突状细胞作为抗癌免疫和免疫治疗的协调者。
Nat Rev Clin Oncol. 2024 Apr;21(4):257-277. doi: 10.1038/s41571-024-00859-1. Epub 2024 Feb 7.
10
Metastatic Hormone-Sensitive Prostate Cancer in the Era of Doublet and Triplet Therapy.转移性激素敏感型前列腺癌在双药和三药治疗时代。
Curr Treat Options Oncol. 2024 Mar;25(3):293-312. doi: 10.1007/s11864-023-01173-1. Epub 2024 Jan 4.